Key result
A normal lung volume < 83.2% on quantitative CT was associated with lower 5-year survival (36.6% vs 81.7%) and was an independent prognostic factor (HR 2.49; 95% CI 1.14-5.44; P=0.022).
Why the study?
It remained unknown whether mortality in patients with concurrent pulmonary hypertension and parenchymal lung diseases is related to low normal lung volume on chest HRCT imaging.
Does the percentage of normal lung volume on quantitative HRCT imaging predict survival and response to pulmonary vasodilators in patients with group 1 and group 3 pulmonary hypertension?
Observational (n=157)
Does the percentage of normal lung volume on quantitative HRCT imaging predict survival and response to pulmonary vasodilators in patients with group 1 and group 3 pulmonary hypertension?
Hazard Ratio: 2.49 (95% CI 1.14–5.44)
Absolute Event Rate: 36.6% vs 81.7%
p-value: p=0.022
Quantitative CT imaging analysis of normal lung volume provides a novel, independent predictor of 5-year survival and vasodilator response in patients with group 1 and group 3 pulmonary hypertension.
May support quantitative CT for PH prognostication; leaves open prospective validation and vasodilator response prediction.
Background Patients with concurrent pulmonary hypertension (PH) and parenchymal lung diseases have a high risk of mortality. However, whether their outcomes are related to low normal lung volume (NLV) resulting from parenchymal lung diseases on chest high-resolution CT (HRCT) imaging remains unknown. Research Question Would NLV on quantitative HRCT imaging affect disease behavior in patients with PH? Study Design and Methods This retrospective observational study evaluated patients with physician-diagnosed group 1 and group 3 PH among 1,471 patients who underwent right heart catheterization. Using a three-dimensional image analysis system for HRCT imaging, the percentage of NLV (–950 to –600 Hounsfield units) to the whole lungs (%NLV) was calculated. The optimal cutoff point of %NLV for predicting survival was examined using the receiver operating characteristic (ROC) curve. The Kaplan-Meier method and Cox proportional hazards regression were used to detect the association between %NLV and prognosis. Multivariable logistic regression was performed to examine the association of %NLV with response to pulmonary vasodilators. Results Overall, 157 patients (mean age, 53.1 ± 17.6 years; sex, n = 111 [70.7%] female patients) were included. ROC curve analysis showed that the optimal cutoff of %NLV for predicting survival was 83.2%. The patients with %NLV of ≥ 83.2% showed significantly higher 5-year survival than that of those with %NLV of < 83.2% (81.7% vs 36.6%; P < . 0001). Multivariable logistic regression analysis revealed %NLV of < 83.2% as an independent prognostic factor (hazard ratio, 2.49 [95% CI, 1.14–5.44]; P = . 022). Responders showed significantly higher %NLV than nonresponders (90.0 ± 5.1% vs 84.7 ± 9.2%; P = . 0002). Multivariable regression analysis showed that only high %NLV predicted response (OR, 1.12 [95% CI, 1.01–1.23]; P = . 016). Interpretation Quantitative CT imaging analysis might allow numerical quantification of the lung condition and vasodilator-treatable area beyond subjective visual assessment in patients with PH. The %NLV could be a novel predictor of prognosis and treatment response in these patients.
No takes yet. Share an insight, caveat, or question.
Shigeta et al. (2024) conducted an observational in Group 1 and group 3 pulmonary hypertension (n=157). Normal lung volume < 83.2% on quantitative HRCT vs. Normal lung volume ≥ 83.2% was evaluated on 5-year survival (HR 2.49, 95% CI 1.14-5.44, p=0.022). A normal lung volume < 83.2% on quantitative CT was associated with lower 5-year survival (36.6% vs 81.7%) and was an independent prognostic factor (HR 2.49; 95% CI 1.14-5.44; P=0.022).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: